These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38950087)

  • 1. Structural Diversification of Pyrazinone Metabolites via Spontaneous Oxa-Michael Addition in
    Lee JR; Hwang SJ; Choi Y; Kim J; Lee GS; Lee BS; Kim KH; Kang KB; Lee HJ; Kim CS
    J Nat Prod; 2024 Jul; 87(7):1881-1887. PubMed ID: 38950087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A family of pyrazinone natural products from a conserved nonribosomal peptide synthetase in Staphylococcus aureus.
    Zimmermann M; Fischbach MA
    Chem Biol; 2010 Sep; 17(9):925-30. PubMed ID: 20851341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of the Nonribosomal Peptide Phevalin and Analogs.
    Ramesh R; Bovino MT; Zeng Y; Aubé J
    J Org Chem; 2019 Mar; 84(6):3647-3651. PubMed ID: 30821453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative biotransformation of pyrazinone-containing corticotropin-releasing factor receptor-1 antagonists: minimizing the reactive metabolite formation.
    Zhuo X; Hartz RA; Bronson JJ; Wong H; Ahuja VT; Vrudhula VM; Leet JE; Huang S; Macor JE; Shu YZ
    Drug Metab Dispos; 2010 Jan; 38(1):5-15. PubMed ID: 19833844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer potential of pyrrole (1, 2, a) pyrazine 1, 4, dione, hexahydro 3-(2-methyl propyl) (PPDHMP) extracted from a new marine bacterium, Staphylococcus sp. strain MB30.
    Lalitha P; Veena V; Vidhyapriya P; Lakshmi P; Krishna R; Sakthivel N
    Apoptosis; 2016 May; 21(5):566-77. PubMed ID: 26852140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paenibacillin A, a new 2(1H)-pyrazinone ring-containing natural product from the endophytic bacterium Paenibacillus sp. Xy-2.
    Bian X; Shao M; Pan H; Wang K; Huang S; Wu X; Xue C; Hua H; Pei Y; Bai J
    Nat Prod Res; 2016; 30(2):125-30. PubMed ID: 25981853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of a pyrazinone-containing thrombin inhibitor. Evidence for novel biotransformation involving pyrazinone ring oxidation, rearrangement, and covalent binding to proteins.
    Singh R; Silva Elipe MV; Pearson PG; Arison BH; Wong BK; White R; Yu X; Burgey CS; Lin JH; Baillie TA
    Chem Res Toxicol; 2003 Feb; 16(2):198-207. PubMed ID: 12588191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butrepyrazinone, a new pyrazinone with an unusual methylation pattern from a Ghanaian Verrucosispora sp. K51G.
    Kyeremeh K; Acquah KS; Camas M; Tabudravu J; Houssen W; Deng H; Jaspars M
    Mar Drugs; 2014 Oct; 12(10):5197-208. PubMed ID: 25325732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Substituted pyrazinone nucleosides--a new family of D4T analogues.
    Batoux N; Granet R; Zerrouki R; Krausz P
    Nucleosides Nucleotides Nucleic Acids; 2009 Sep; 28(9):866-73. PubMed ID: 20183624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubulin modulating antifungal and antiproliferative pyrazinone derivatives.
    Taggi AE; Stevenson TM; Bereznak JF; Sharpe PL; Gutteridge S; Forman R; Bisaha JJ; Cordova D; Crompton M; Geist L; Kovacs P; Marshall E; Sheth R; Stavis C; Tseng CP
    Bioorg Med Chem; 2016 Feb; 24(3):435-43. PubMed ID: 26386818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity and In vivo efficacy of Isoliquiritigenin against Staphylococcus xylosus ATCC 700404 by IGPD target.
    Qu Q; Wang J; Cui W; Zhou Y; Xing X; Che R; Liu X; Chen X; Bello-Onaghise G; Dong C; Li Z; Li X; Li Y
    PLoS One; 2019; 14(12):e0226260. PubMed ID: 31860659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
    Parlow JJ; Case BL; Dice TA; Fenton RL; Hayes MJ; Jones DE; Neumann WL; Wood RS; Lachance RM; Girard TJ; Nicholson NS; Clare M; Stegeman RA; Stevens AM; Stallings WC; Kurumbail RG; South MS
    J Med Chem; 2003 Sep; 46(19):4050-62. PubMed ID: 12954058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise synthesis of an enantiopure bicyclic pyrazinone as constrained peptidomimetic building block.
    Gembus V; Janvier S; Lecouvé JP; Vaysse-Ludot L; Brière JF; Levacher V
    Org Biomol Chem; 2012 Mar; 10(10):2003-7. PubMed ID: 22302309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhypyrazinones A and B, Pyrazinone Natural Products from a Marine-Derived Myxobacterium
    Zhang F; Braun DR; Rajski SR; DeMaria D; Bugni TS
    Mar Drugs; 2019 Dec; 17(12):. PubMed ID: 31842310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel synthesis of arylpyrrolo[1,2-a]pyrazinone derivatives.
    Wang F; Wang J; Zhang S
    Molecules; 2004 Jun; 9(7):574-82. PubMed ID: 18007457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of pyrazinone ring-containing opioid mimetics and examination of their opioid receptor-binding activity.
    Okada Y; Fukumizu A; Takahashi M; Yokoi T; Tsuda Y; Bryant SD; Lazarus LH
    Chem Pharm Bull (Tokyo); 1999 Aug; 47(8):1193-5. PubMed ID: 10478476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid-phase synthesis of the 2(1H)-pyrazinone scaffold: a new approach toward diversely substituted heterocycles.
    Kaval N; Dehaen W; Van der Eycken E
    J Comb Chem; 2005; 7(1):90-5. PubMed ID: 15638486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of pyrazinone based compounds that potently inhibit the drug-resistant enzyme variant R155K of the hepatitis C virus NS3 protease.
    Belfrage AK; Abdurakhmanov E; Kerblom E; Brandt P; Oshalim A; Gising J; Skogh A; Neyts J; Danielson UH; Sandström A
    Bioorg Med Chem; 2016 Jun; 24(12):2603-20. PubMed ID: 27160057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrazinone protease inhibitor metabolites from Photorhabdus luminescens.
    Park HB; Crawford JM
    J Antibiot (Tokyo); 2016 Aug; 69(8):616-21. PubMed ID: 27353165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of opioidmimetics containing 2',6'-dimethyl-L-tyrosine and a pyrazinone-ring platform.
    Shiotani K; Li T; Miyazaki A; Tsuda Y; Yokoi T; Ambo A; Sasaki Y; Bryant SD; Lazarus LH; Okada Y
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5768-71. PubMed ID: 17826995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.